During the past decade, University of the Ryukyus Hospital conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 8 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 7 clinical trials were completed. i.e. 77.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of the Ryukyus Hospital" #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "Janssen Research & Development, LLC" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Cook Group Incorporated" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of the Ryukyus Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 2 trials as a collaborator, "Genmab" with 1 trials as a collaborator and "NRG Oncology" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "University of the Ryukyus Hospital" are "Psoriasis" (3 trials), "Aortic Dissection" (1 trials), "Atypical Endometrial Hyperplasia" (1 trials), "Cervical Cancer" (1 trials) and "Choriocarcinoma" (1 trials). Many other conditions were trialed in "University of the Ryukyus Hospital" in a lesser frequency.

Most popular intervention types in "University of the Ryukyus Hospital" are "Drug" (15 trials), "Other" (4 trials), "Biological" (1 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Mirikizumab" (3 trials), "Docetaxel" (2 trials), "Faricimab" (2 trials) and "Laboratory Biomarker Analysis" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of the Ryukyus Hospital" are 12 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University of the Ryukyus Hospital". undefined are not yet recruiting, 2 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in University of the Ryukyus Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University of the Ryukyus Hospital, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

University of the Ryukyus Hospital has several departments that took part in Clinical trials: "Graduate School of Medical Science at the University of Ryukyu" - 2 trials